DR. BRUCE HENRY LITTMAN, M.D.
Osteopathic Medicine at Prentice Williams Rd, Stonington, CT
License number
Connecticut 030425
Category
Osteopathic Medicine
Type
Rheumatology
Address
Address
28 Prentice Williams Rd, Stonington, CT 06378
Phone
(860) 303-6954
(860) 572-7586 (Fax)
(860) 572-7586 (Fax)
Professional information
Dr. Bruce H Littman, Stonington CT - MD (Doctor of Medicine)
Specialties:
Rheumatology
Address:
28 Prentice Williams Rd, Stonington 06378
Certifications:
Internal Medicine, 1975, Rheumatology, 1978
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
State University of New York At Buffalo
Tufts New England Medical Center
Rb Brigham Hosp-Harvard
State University of New York At Buffalo
Tufts New England Medical Center
Rb Brigham Hosp-Harvard
6-Chloro-5-Fluoro-3-(2-Thenoyl)-2-Oxindole-1-Carboxamide As An Analgesic And Anti-Inflammatory Agent While Maintaining A Normal Urine Protein/Creatinine Ratio
US Patent:
5298522, Mar 29, 1994
Filed:
Jan 22, 1993
Appl. No.:
8/007217
Inventors:
Kelvin Cooper - Nonak CT
Bruce H. Littman - Stonington CT
Christopher J. Pazoles - Waterford CT
Keith D. Wilner - Groton CT
Bruce H. Littman - Stonington CT
Christopher J. Pazoles - Waterford CT
Keith D. Wilner - Groton CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 3140
US Classification:
514414
Abstract:
A method of producing analgesia and treating antiinflammatory disease in a human subject while avoiding proteinuria by administering 6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide or a pharmaceutically-acceptable base salt thereof.
Methods For Treating Osteoarthritis Using An Estrogen Agonist / Antagonist
US Patent:
6777424, Aug 17, 2004
Filed:
Sep 19, 2001
Appl. No.:
09/956696
Inventors:
Bruce H. Littman - Stonington CT
Assignee:
Pfizer Inc. - New York NY
International Classification:
A61K 3147
US Classification:
514307, 514345, 514681, 514682, 514317, 514331, 514428, 514213
Abstract:
The present invention provides methods and kits for treating osteoarthritis using an estrogen agonist/antagonist.
Methods For Treating Osteoarthritis Using An Estrogen Agonist/Antagonist
US Patent:
2004015, Aug 12, 2004
Filed:
Jan 22, 2004
Appl. No.:
10/762617
Inventors:
Bruce Littman - Stonington CT, US
Assignee:
Pfizer Inc
International Classification:
A61K031/506, A61K031/4709, A61K031/517
US Classification:
514/256000, 514/266200, 514/340000, 514/310000, 514/314000
Abstract:
The present invention provides methods and kits for treating osteoarthritis using an estrogen agonist/antagonist.